Skip to search.
 BSE Down 0.42% NSE Down 0.52%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
4.82 Up 0.16(3.43%) 1:21am - Nasdaq Real Time Price
Prev Close:4.66
Open:4.66
Bid:4.80 x 600
Ask:4.81 x 4900
1y Target Est:13.00
Beta:2.4108
Earnings Date:8 Aug - 12 Aug (Est.)
Day's Range:4.63 - 4.94
52wk Range:4.45 - 14.93
Volume:1,425,124
Avg Vol (3m):2,590,220
Market Cap:627.67M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPUp 3.43%627.67M
IMGNDown 0.71%242.94M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):100.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.42
Quarterly EPS Est (Jun-16) :-0.11
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback